Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Licensing opportunity from LG Chemical: broad-spectrum catechol-substituted cephalosporin

May 4, 1999

Micrologix completes phase I trial for prevention of bloodstream infections

May 3, 1999

NDA filed for first oral neuraminidase inhibitor for the flu

April 30, 1999

New oxazolidinones claimed by Zeneca (AstraZeneca)

April 30, 1999

Chinese investigators develop new antimicrobial agents

April 28, 1999

Pentose and Cangene enter licensing agreement

April 26, 1999

Abbott obtains marketing rights to Meiji cephalosporin in several major markets

April 23, 1999

Immunotherapeutic method of treating viral respiratory disease available from NIH

April 23, 1999

Amoxil cleared for b.i.d. dosing in children

April 22, 1999

Oxazolidinones useful for resistant Gram-positive infections

April 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....